Literature DB >> 25052748

Liposarcoma miRNA signatures identified from genome-wide miRNA expression profiling.

Yuhong Zhou1, Yong Zhang, Yuan Huang, Ruoying Tan, Tianshu Liu, Rongyuan Zhuang, Miaojun Zhu, Wumei Han, Yingyong Hou, Ju Liu, Li Zhang, Yaping Jiang, Hanxing Tong, Yebo Shao, Jun Zhu, Weiqi Lu.   

Abstract

AIMS: To identify the miRNA expression profile of liposarcoma (LPS) that could facilitate detection of LPS, and provide the basis for further investigation of molecular-targeted therapeutic drugs. MATERIALS &
METHODS: A real-time quantitative PCR assay was performed to analyze the expression of 1888 miRNAs from 25 LPS tumor tissue samples, 16 samples of adipose tissue adjacent to the tumors and 18 normal adipose tissue samples from patients with LPS.
RESULTS: Ten dysregulated miRNAs were identified that effectively distinguished LPS tissue from adipose tissue and benign lipoma tissue, and LPS tumor tissues from normal adipose tissues in LPS patients. Furthermore, the expression profiles of miRNAs could also classify the subtype of LPS.
CONCLUSION: The identified miRNAs appear to be novel biomarkers for the detection of LPS, and may contribute to an understanding of the mechanisms of LPS tumorigenesis and its development, and further elucidate the characteristics of LPS subtypes.

Entities:  

Keywords:  RT-quantitative PCR; dysregulation; liposarcoma; miRNAs

Mesh:

Substances:

Year:  2014        PMID: 25052748     DOI: 10.2217/fon.14.90

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  6 in total

Review 1.  Liposarcoma: molecular targets and therapeutic implications.

Authors:  Kate Lynn J Bill; Lucia Casadei; Bethany C Prudner; Hans Iwenofu; Anne M Strohecker; Raphael E Pollock
Journal:  Cell Mol Life Sci       Date:  2016-05-12       Impact factor: 9.261

2.  Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression.

Authors:  Lucia Casadei; Federica Calore; Chad J Creighton; Michele Guescini; Kara Batte; O Hans Iwenofu; Abeba Zewdu; Danielle A Braggio; Kate Lynn Bill; Paolo Fadda; Francesca Lovat; Gonzalo Lopez; Pierluigi Gasparini; James L Chen; Raleigh D Kladney; Gustavo Leone; Dina Lev; Carlo M Croce; Raphael E Pollock
Journal:  Cancer Res       Date:  2017-06-06       Impact factor: 12.701

Review 3.  Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.

Authors:  Jun Lu; David Wood; Evan Ingley; Sulev Koks; Daniel Wong
Journal:  Mol Biol Rep       Date:  2021-04-24       Impact factor: 2.316

4.  Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.

Authors:  Nikolaos Kapodistrias; Konstantinos Mavridis; Anna Batistatou; Penelope Gogou; Vasilios Karavasilis; Ioannis Sainis; Evangelos Briasoulis; Andreas Scorilas
Journal:  Oncotarget       Date:  2017-01-24

5.  Establishing a patient-derived xenograft model of human myxoid and round-cell liposarcoma.

Authors:  Yiming Qi; Yu Hu; Hua Yang; Rongyuan Zhuang; Yingyong Hou; Hanxing Tong; Yi Feng; Yuan Huang; Quan Jiang; Qunsheng Ji; Qingyang Gu; Zhixiang Zhang; Xuzhen Tang; Weiqi Lu; Yuhong Zhou
Journal:  Oncotarget       Date:  2017-04-21

6.  Long Non-Coding RNA LINC01410 Promoted Tumor Progression via the ErbB Signaling Pathway by Targeting STAT5 in Gallbladder Cancer.

Authors:  Lili Lu; Shilong Zhang; Zhengqing Song; Weiqi Lu; Zhiming Wang; Yuhong Zhou
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.